Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects

This study has been completed.
ViiV Healthcare
Information provided by:
Pfizer Identifier:
First received: October 8, 2010
Last updated: May 16, 2011
Last verified: May 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2011
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)